Shenzhen Capital Group led Maxvax Biotechnology’s Series C round, while VMS Group co-led Hope Medicine’s extended Series B round. Also, Gree Financial Investment joined Robestec’s Series A round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
